secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2025-04-16T23:59:59+00:00
Accession:  0001558370-25-004898
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech director Lucy Lu resigns from board, to become Chief Strategy Officer on April 21
--------------------------------------------------------------------------------

- Lucy Lu resigned from the Board of Directors effective April 15, 2025, with no disagreement with the Company.
- She accepted an offer to join Fortress Biotech as Chief Strategy Officer effective April 21, 2025.
- Dr. Lu will transition from board oversight to an executive leadership role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000155837025004898/0001558370-25-004898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000155837025004898/fbio-20250415x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-004898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer